Clinlab Navigator


Malignant mesothelioma is a rare but highly aggressive neoplasm with poor prognosis. Epidemiologic studies have established exposure to asbestos fibers as the primary cause of malignant mesothelioma.

As of May 2022, MESOMARK® (Fujirebio Diagnostics) was the only FDA approved blood-based biomarker test for mesothelioma. It is an enzyme-linked immunosorbent assay (ELISA) for the quantitative measurement of soluble mesothelin-related peptides (SMRPs), which are released into the bloodstream by mesothelioma cells.

MESOMARK results alone are not sufficient to diagnose mesothelioma. The MESOMARK label states the test can help monitor patients with epithelioid mesothelioma and biphasic mesothelioma but not sarcomatoid mesothelioma.

Reference interval is 0.0 – 1.5 nmol/L. Patients with mesothelioma have higher SMRP levels than healthy patients. 

Specimen requirement is q serum separator tube or plain red top tube of blood. MESOMARK is available at ARUP Laboratories. 


Beyer, H. et al. MESOMARK™: A Potential Test for Malignant Pleural Mesothelioma. Clinical Chemistry, 2007;53:666-672.

Schneider J, et al. Diagnostic and Prognostic Value of Soluble Mesothelin-Related Proteins in Patients with Malignant Pleural Mesothelioma in Comparison with Benign Asbestosis and Lung Cancer, J Thorac Oncol. 2008; 3:1317–1324.

Updated Articles

C1 Esterase Inhibitor

Hereditary angioedema is caused by a deficiency or dysfunction of C1 esterase inhibitor (C1-INH). C1 esterase inhibitor is a serum alpha-2 globulin and a member of the serpin family of protease inhibitors that is primarily synthesized by the liver.…

New Articles

Babesia microti

Babesiosis is a tickborne zoonotic disease that is caused primarily by the intraerythrocytic parasite Babesia in the United States. The first case of human babesiosis acquired in the United States was identified in 1969 on Nantucket Island,…


Quantity of…

SARS-CoV-2, the causative agent of COVID-19, spreads through exhaled breath during breathing, coughing, talking, and singing. Olfactory scientists at Northwestern University Feinberg School of Medicine developed a portable device for the collection…